CONTACT US
Search
Close this search box.

‘The Whole World Is In Overdose,’ Says CEO Of SyqeAir About the Groundbreaking Cannabis Inhaler

An article in Benzinga highlights Syqe® Medical’s innovative SyqeAir Inhaler, emphasizing its role in addressing the global challenge of cannabis overdose through metered dosing. CEO of SyqeAir, Hagit Kamin, discusses how the Inhaler and Cartridges allow patients to achieve fast relief in the intensity of chronic neuropathic pain and PTSD symptoms without the risk of overdose. The article underscores Syqe®’s commitment to a safer yet equally effective medical cannabis treatment and marks another prestigious acknowledgment for the company. Read the full article>>

Leave a Reply

Your email address will not be published. Required fields are marked *

Medical Cannabis
SyqeAir Inhaler
Useful Information
Media
Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

SyqeAir logo white
The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.
Skip to content